This phase I/II trial tests the side effects and best dose of abemaciclib when added to gemcitabine and compares the effectiveness of that treatment to the usu…

Advanced Dedifferentiated LiposarcomaAdvanced LeiomyosarcomaAdvanced Soft Tissue Sarcoma+5 more

~Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT06498648

Phase 1

A Phase I Trial of Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma

The investigators hypothesize that the combination of eribulin and zanzalintinib will be tolerable and lead to improved progression-free survival (PFS) as comp…

Advanced LeiomyosarcomaAdipocytic SarcomaAdvanced Liposarcoma

~Estimated

~$10 – $6,250

Washington University School of MedicineNCT06957431